Jaguar Health, Inc. (NASDAQ:JAGX) Short Interest Up 49.7% in February

Jaguar Health, Inc. (NASDAQ:JAGX) saw a large growth in short interest in February. As of February 28th, there was short interest totalling 953,100 shares, a growth of 49.7% from the February 13th total of 636,700 shares. Currently, 7.6% of the company’s stock are sold short. Based on an average trading volume of 471,800 shares, the short-interest ratio is presently 2.0 days.

Hedge Funds Weigh In On Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC purchased a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health as of its most recent filing with the Securities & Exchange Commission. 12.04% of the stock is owned by institutional investors and hedge funds.

Jaguar Health Price Performance

Shares of NASDAQ JAGX traded down $0.00 during mid-day trading on Friday, hitting $0.45. The company had a trading volume of 305,925 shares, compared to its average volume of 409,586. The firm has a 50-day simple moving average of $0.81 and a two-hundred day simple moving average of $0.99. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.84 and a quick ratio of 1.36. Jaguar Health has a one year low of $0.42 and a one year high of $21.60.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.